BioPharm International eBulletin
Having trouble viewing this e-mail? CLICK HERE
BioPharm International
December 04, 2018
WEBSITE CURRENT ISSUE SUBSCRIBE FORWARD
ADVERTISEMENT

Top Stories

WuXi Biologics Begins Construction of Major Biologics Center in China

The new center will integrate biologics drug discovery, development, clinical manufacturing, and commercial manufacturing.
/ read more /


GE Healthcare Opens Biotechnology Manufacturing Center in UK

GE's new facility, which will be operational in 2019, will produce a fiber-based chromatography platform for more efficient biopharmaceutical purification.
/ read more /

Subscribe

Subscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.

subscription offers
subscribe
advertisement

ADVERTISEMENT

Industry News

NIBRT, Valitacell Aim to Validate New Analytical Technology

The partnership, co-funded by Enterprise Ireland, will develop technologies for monitoring the quality of biopharma processes.
/ read more /


International Partnership Aims to Develop Needle-free Vaccines

The University of South Australia is working to develop needle-free vaccines for Zika, chikingunya, and peanut allergy in a collaboration with Australian biotechnology company Sementis and Enesi Pharma, a United Kingdom-based pharmaceutical company.
/ read more /


More Industry News
advertisement

Biopharma News

Seqirus Announces $140-Million Expansion for Vaccine Facility

The vaccine producer announced an expansion to its Holly Springs, NC, manufacturing facility where it will increase production of its cell-based quadrivalent influenza vaccine.
/ read more /


Genentech Acquires Jecure Therapeutics

The acquisition will give Genentech full rights to Jecure's preclinical portfolio of NLRP3 inhibitors.
/ read more /


More Biopharma News
advertisement
ADVERTISEMENT

Process Development Forum

Need to optimize your manufacturing systems? Find insights, solutions, and shortcuts in bioprocessing at ProcessDevelopmentForum.com
Learn more »


Supplier News

QPS Expands US-Based Phase I Clinical Trial Capabilities

The contract research organization has increased its US-based early phase clinical capacity and doubled its specialty lab space.
/ read more /

 

Cobra, Pall, and Partner Receive $1.9 Million to Study Continuous Manufacturing of Adeno-Associated Virus Vectors for Gene Therapy

Cobra, Pall, and Cell and Gene Therapy Catapult are collaborating to develop continuous manufacturing for gene therapy production.
/ read more /


More Supplier News

Regulatory News

Quality Manufacturing Key to Reducing Drug Shortages

Despite ongoing efforts to address the problem, FDA now sees a rise in active shortages and in the duration of supply problems.
/ read more /


 

EMA Recommends Four Medicines for Approval

The positive opinions included the first oral-only tablet for the treatment of human African trypanosomiasis.
/ read more /


More Regulatory News


FEATURE TOPICS

DRUG DELIVERY

Innovations in Prefilled Syringes for Biologic Drugs

As biologic drugs grow increasingly complex, drug delivery mechanisms such as prefilled syringes are being adapted to meet the challenges.
/ read more /

 

UPSTREAM PROCESSING

Media Requirements for Different Cell Sources

This article will explore the requirements for media and supplements needed to maintain newer cell lines, such as those based on human cells and fungal cells.
/ read more /


FACILITIES

Impact of ATMP Manufacturing on Process Equipment and Facility Design

Advanced therapy medicinal products pose unique manufacturing challenges that will require appropriate and thoughtful facility design and equipment.
/ read more /

MANUFACTURING

Single-Use Mixing Technology for Virus Clearance (Part 2: Compatibility, Leachables, and Scale-Up Studies)

The second half of this article describes the testing methods used by the authors to demonstrate the applicability of single-use mixing technology for virus inactivation.
/ read more /


UPCOMING WEBCASTS

Understanding Absolute Stoichiometry of Oligomeric Protein Complexes using SEC-MALS
Tuesday, January 29, 2019 at 11am EST| 8am PST| 4pm GMT| 5pm CET
Register now


Optimizing SEC for Analysis of Antibodies and Antibody–Drug Conjugates
Monday, December 10, 2018 at 11am EST|8am PST|4pm GMT|5pm CET
Register now


Screen Hundreds of N-Glycans per Day: More Samples – Better Decisions – Faster
Friday, December 7, 2018 at 11am EST|8am PST|4pm GMT|5pm CET
Register now


Events

2018 ISPE Biopharmaceutical Manufacturing Conference

December 10–12, 2018

Pharmaceutical Microbiology UK 2019

January 21–23, 2019

2019 PDA Annual Meeting

March 11–13, 2019

more events

eBook

Biopharma Laboratory Best Practices 2018 eBook

This eBook covers method development, analytical techniques, and profiles of new instruments, equipment, and supplies used in the testing and analysis of raw materials, drug substances, and drug products.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise